Ginkgetin Pretreatment Reduces Inflammatory Response in DCD Donor Liver via JAK2/STAT3 Signaling PathwayJia Liu(Nanjing Tech University), Qi Xiao(Chongqing Emergency Medical Center)Annals of TransplantationMay 29, 202410.12659/aot.944153Cited by 4SaveCiteExport RISWatch citationsRelated PapersComprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer|Cell Reports|2018|521